![Andrea Lisziewicz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrea Lisziewicz
Nessuna posizione attualmente
Profilo
Andrea Lisziewicz is Director of Finance and Administration for Genetic Immunity LLC.
She joined Genetic Immunity in 2005 and became Director of Business Administration in September, 2006 and Director of Finance and Administration in June 1, 2007.
Ms. Lisziewicz co-founded L&Mark kft in 1992 and currently serves as General Manager.
She worked with Siemens AG from 1986 to 1992.
Ms. Lisziewicz has 15 years of experience in small technology-oriented business administration.
She received an MS degree in Informatics from the Technical University of Dresden in 1986 and an MBA degree in 2004 from the Technical University of Budapest.
Precedenti posizioni note di Andrea Lisziewicz
Società | Posizione | Fine |
---|---|---|
SIEMENS AG | Corporate Officer/Principal | 01/01/1992 |
Genetic Immunity, Inc.
![]() Genetic Immunity, Inc. Pharmaceuticals: OtherHealth Technology Genetic Immunity LLC develops nanomedicines for immune amplification. It offers an immunetherapy platform technology that includes a plasmid DNA based antigen, a nanomedicine formulation, and a topical administration device that targets antigens to dendritic cells. The company was founded by Julianna Lisziewicz and is headquartered in McLean, VA. | Direttore Finanziario/CFO | - |
Formazione di Andrea Lisziewicz
Technical University of Berlin | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SIEMENS AG | Producer Manufacturing |
Aziende private | 1 |
---|---|
Genetic Immunity, Inc.
![]() Genetic Immunity, Inc. Pharmaceuticals: OtherHealth Technology Genetic Immunity LLC develops nanomedicines for immune amplification. It offers an immunetherapy platform technology that includes a plasmid DNA based antigen, a nanomedicine formulation, and a topical administration device that targets antigens to dendritic cells. The company was founded by Julianna Lisziewicz and is headquartered in McLean, VA. | Health Technology |
- Borsa valori
- Insiders
- Andrea Lisziewicz